Gilead Sciences, Inc. May Get FDA Warning Letter For California Facility

August 10, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK (Dow Jones)--Gilead Sciences Inc. (GILD) said it may receive a warning letter from the Food and Drug Administration after an inspection of its San Dimas, Calif., manufacturing and distribution facility found a number of problems.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory

Gilead Sciences, Inc. Food and Drug Administration (FDA)